Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

4(66.7%)

Phase 2

1(16.7%)

N/A

1(16.7%)

6Total

Phase 1(4)

Phase 2(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07488247Phase 2Completed

Phase IIb and III Safety and Efficacy Study Chlorin E6 Gel Photodynamic Therapy for Diabetic Foot Ulcers:

Role: collaborator

NCT05847218Phase 1Completed

Phase 1 Clinical Trial of RHN-001 in Healthy Adult Volunteers

Role: collaborator

NCT04873570Phase 1Completed

Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects

Role: collaborator

NCT05436886Not ApplicableCompleted

Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules

Role: collaborator

NCT05436769Phase 1Completed

Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet

Role: collaborator

NCT05186129Phase 1Completed

Bioequivalence Study of Clopid® (Clopidogrel) 75 mg Tablet and Plavix® 75 mg Tablet After Oral Administration to Healthy Adult Subjects Under Fasting Condition

Role: lead

All 6 trials loaded